Health Care Equipment and Supplies Health Care Equipment

  • BOSTON— Tufts University in Boston is receiving a $15 million donation to expand its anatomy lab where medical students dissect cadavers. Tufts plans to build an expanded anatomy lab with new medical imaging equipment and room for more than 200 students and faculty. Medical students at Tufts and many other schools learn anatomy by dissecting cadavers.

  • Sept 8- Medical device maker Abbott Laboratories and Alere Inc agreed on Thursday to work with a mediator to settle their dispute over Abbott's role in obtaining U.S. antitrust clearance for its $5.8 billion takeover of the diagnostics company, but Alere voiced concern about the speed of the process. The companies are considering using former Delaware...

  • Sept 6- Danaher Corp said on Tuesday it would buy molecular diagnostics company Cepheid in a deal valued at $4 billion, including debt, to strengthen its diagnostics business. Danaher will pay $53 per share in cash, a premium of 54 percent to Cepheid's close of $34.42 on Friday. 1/ 8 nPn10sKcxa. Cepheid had revenue of $539 million last year, and is expecting $618...

  • Aug 31- Tecomet Inc, a privately held U.S. contract manufacturer of medical devices and surgical instruments, is exploring a sale that could value it at more than $1 billion, including debt, according to people familiar with the matter. Genstar Capital, the private equity firm that owns Tecomet, has hired investment bank William Blair& Company, LLC to run an auction...

  • St. Jude reopens

    St. Jude reopens, with fractionally higher stocks, CNBC's Bob Pisani reports.

  • The report, which caused St Jude shares to decline after its release on Thursday, alleged there were significant security bugs in the company's Merlinzhome device for monitoring implanted heart devices. St. Jude initially responded on Thursday with a terse statement from its chief technology officer, Phil Ebeling, who said "the allegations are absolutely...

  • Aug 26- Medical device manufacturer St. Jude Medical Inc said on Friday that a report by short-selling firm Muddy Waters and a cyber-security researcher alleging its heart devices were riddled with bugs was "false and misleading." The report, which caused St Jude shares to decline after its release on Thursday, alleged there were significant security bugs in the...

  • Jude Medical Inc fell sharply on Thursday after short-selling firm Muddy Waters said it had placed a bet that the shares would fall, claiming its implanted heart devices were vulnerable to cyber attacks. Muddy Waters head Carson Block said the firm's position was motivated by research from a cyber security firm, MedSec Holdings Inc, which has a financial...

  • Aug 25- The stock of pacemaker manufacturer St Jude Medical Inc fell sharply on Thursday after short-selling firm Muddy Waters said it had placed a bet that the shares would fall because of cyber security vulnerabilities in the company's cardiac devices. Muddy Waters head Carson Block said his short position in St Jude was motivated by research from a cyber...

  • Aug 25- Shares of medical device maker St Jude Medical Inc fell sharply on Thursday after short-selling firm Muddy Waters said it had placed a bet that the shares would fall because of cyber security vulnerabilities in cardiac devices made by St Jude. Muddy Waters head Carson Block said his short position in St Jude was motivated by research from a cyber...

  • Aug 25- Shares of medical device maker St Jude Medical Inc fell sharply on Thursday after short-selling firm Muddy Waters said it had placed a bet that the shares would fall because of cyber security vulnerabilities in a cardiac device. Shares of St Jude, which agreed in April to be purchased by Abbott Laboratories, were last down nearly 4 percent on heavy volume...

  • Aug 18- The U.S. Food and Drug Administration has widened the use of Edwards Lifesciences Corp's heart valves to patients at intermediate risk of complications if they underwent open heart surgery. The devices, Sapien XT and Sapien 3, have already been approved for use in patients unlikely to survive open-heart surgery or are at high risk for complications.

  • WELLINGTON, Aug 18- ResMed Inc said on Thursday it has filed legal action to stop the alleged infringement of its patented technology by New Zealand- based medical device manufacturer Fisher& Paykel Healthcare. ResMed said in a statement it filed legal action with the U.S. International Trade Commission and the U.S. District Court for the Southern District of...

  • In this image provided by Sanofi and Regeneron Pharmaceuticals, shows packaging for the drug Praluent.

    A cholesterol-lowering drug, priced at $14,000 a year per person, could add billions to US health care costs, USA Today reports.

  • Excluding one-time items, Edwards said second-quarter earnings rose to 76 cents a share from 57 cents in the year-ago period. The Irvine, California- based company raised its full-year forecast, excluding items, by 11 cents, to a range of $2.78 to $2.88 a share. It now expects sales to be at the high end of the range of its previous forecast of $2.7 billion to $3 billion.

  • Edwards earned 76 cents a share, excluding one-time items, in the second quarter. Analysts on average had expected 70 cents a share, according to Thomson Reuters I/B/E/S. The Irvine, California- based medical device maker raised its full-year forecast, excluding items, by 11 cents, to a range of $2.78 to $2.88 a share.

  • July 21- Theranos Inc hired two executives to oversee regulatory, quality and compliance standards, in a bid to turn around the struggling blood-testing company after it received sanctions from U.S. regulators. He will work on getting FDA clearances and approvals, marketing new products, and look into medical-device quality systems. The company, once valued at...

  • July 19- Two former executives of Acclarent Inc, a medical device company bought by Johnson& Johnson in 2010, were convicted on Wednesday by a U.S. jury on charges of promoting a product for an unapproved use. Former Acclarent Chief Executive William Facteau and former Vice President of Sales Patrick Fabian were found guilty in federal court in Boston of 10...

  • July 19- Two former executives of Acclarent Inc, a medical device company bought by Johnson& Johnson in 2010, were convicted on Wednesday by a U.S. jury on charges of promoting a product for an unapproved use. Former Acclarent Chief Executive William Facteau and former Vice President of Sales Patrick Fabian were found guilty in federal court in Boston of 10...

  • *Results affected by Venezuela operations. July 20- Abbott Laboratories reported better-than-expected quarterly sales and profit as strong sales in its medical device business more than made up for the hit from an economic turmoil in Venezuela. Abbott is one of the major U.S. companies to be affected by troubled operations in Venezuela.